News
Since Bioiberica was founded in 1975, Heparin has been one of the companys most important products.
Bioiberica has created a New Technologies Division with the aim of addressing the needs of all patients suffering from chondral pathologies, while taking a further step away from conventional therapy towards more specific, personalized and effective treatments for every patient.
As in previous years, Bioiberica attended the CPHI tradeshow in October in Madrid and also the Supplyside West in November in Las Vegas.
It was a pleasure to see you there. We look forward to attending again next year.
Bioiberica has revamped its corporate website to make it more up to date, operative and interesting for different audiences.
With the aim of promoting scientific research at the rheumatology units of Spanish hospitals and the continuous training of rheumatologists, the Spanish Rheumatology Society (SER), in conjunction with Bioiberica, provides grants to allow researchers to attend the OARSI World Congress on Osteoarthritis.